Does IBRUTINIB Cause Chronic graft versus host disease? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Chronic graft versus host disease have been filed in association with IBRUTINIB (Imbruvica). This represents 0.1% of all adverse event reports for IBRUTINIB.
108
Reports of Chronic graft versus host disease with IBRUTINIB
0.1%
of all IBRUTINIB reports
12
Deaths
7
Hospitalizations
How Dangerous Is Chronic graft versus host disease From IBRUTINIB?
Of the 108 reports, 12 (11.1%) resulted in death, 7 (6.5%) required hospitalization, and 3 (2.8%) were considered life-threatening.
Is Chronic graft versus host disease Listed in the Official Label?
Yes, Chronic graft versus host disease is listed as a known adverse reaction in the official FDA drug label for IBRUTINIB.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Chronic graft versus host disease?
CYCLOSPORINE (1,012)
MYCOPHENOLATE MOFETIL (848)
METHOTREXATE (708)
TACROLIMUS (659)
CYCLOPHOSPHAMIDE (531)
FLUDARABINE (420)
RUXOLITINIB (321)
BUSULFAN (309)
PREDNISONE (251)
RITUXIMAB (244)
Which IBRUTINIB Alternatives Have Lower Chronic graft versus host disease Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE